Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Attending rounds: a patient with accelerated hypertension and an atrophic kidney.

Textor SC.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1117-23. doi: 10.2215/CJN.09030813. Epub 2014 Jan 9.

2.

Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER).

Scarpioni R, Michieletti E, Cristinelli L, Ugolotti U, Scolari F, Venturelli C, Cancarini G, Pecchini P, Malberti F, Maroldi R, Rozzi G, Olivetti L.

J Nephrol. 2005 Jul-Aug;18(4):423-8.

PMID:
16245247
3.

A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure.

Roussos L, Christensson A, Thompson O.

Nephron Clin Pract. 2006;104(3):c132-42. Epub 2006 Aug 7.

PMID:
16899992
4.

[The kidneys and hypertension].

Hausberg M, Mann J, Kühn K.

Dtsch Med Wochenschr. 2008 Sep;133(37):1853-6. doi: 10.1055/s-0028-1082809. Epub 2008 Sep 3. Review. German.

PMID:
18770487
5.

Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.

Sofroniadou S, Kassimatis T, Srirajaskanthan R, Reidy J, Goldsmith D.

Int Urol Nephrol. 2012 Oct;44(5):1451-9. doi: 10.1007/s11255-011-0091-y. Epub 2011 Nov 30.

PMID:
22127407
6.

Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate.

Saad A, Herrmann SM, Crane J, Glockner JF, McKusick MA, Misra S, Eirin A, Ebrahimi B, Lerman LO, Textor SC.

Circ Cardiovasc Interv. 2013 Aug;6(4):428-35. doi: 10.1161/CIRCINTERVENTIONS.113.000219. Epub 2013 Jul 30.

7.

Plasma renin activity testing to guide triple antirenin system drug therapy in a patient with difficult-to-treat hypertension.

Shah S, Coakley C, Hough A, Parra D.

Ann Pharmacother. 2014 Feb;48(2):279-85. doi: 10.1177/1060028013512788. Epub 2013 Nov 18.

PMID:
24259655
8.

[Ischemic renal disease: revascularization or conservative treatment?].

Rodríguez Jornet A, Ibeas J, Ribera L, Real J, Perendreu J, Falcó J, Vallespín J, Allegué N, Giménez Gaibar A, García García M.

Nefrologia. 2005;25(3):258-68. Review. Spanish.

9.

[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].

Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.

Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. Serbian.

10.

Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.

Abe M, Suzuki H, Okada K, Maruyama N, Inoshita A, Baba S, Takashima H, Soma M.

Heart Vessels. 2013 Jul;28(4):442-52. doi: 10.1007/s00380-012-0260-7. Epub 2012 May 23.

PMID:
22618635
11.

Plasma renin activity testing to guide triple antirenin system drug therapy in a patient with difficult-to-treat hypertension.

Shah S, Coakley C, Hough A, Parra D.

Ann Pharmacother. 2013 Nov;47(11):1562-8. doi: 10.1177/1060028013501142.

PMID:
24285769
12.

Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.

Jaff MR, Bates M, Sullivan T, Popma J, Gao X, Zaugg M, Verta P; HERCULES Investigators.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):343-50. doi: 10.1002/ccd.24449. Epub 2012 Jun 27.

PMID:
22511402
13.

[Predictors of successful renal artery revascularization in atherosclerotic renovascular disease].

Flisiński M, Manitius J.

Pol Merkur Lekarski. 2005 Aug;19(110):206-10. Review. Polish.

PMID:
16245436
14.

Renal arterial intervention and angiotensin blockade in atherosclerotic nephropathy.

Goldsmith DJ, Reidy J, Scoble J.

Am J Kidney Dis. 2000 Oct;36(4):837-43.

PMID:
11007688
15.

Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.

Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M, Kuntz R, Jamerson K, Reid D, Rosenfield K, Rundback J, D'Agostino R, Henrich W, Dworkin L.

Am Heart J. 2006 Jul;152(1):59-66.

PMID:
16824832
16.

Can lercanidipine improve renal function in patients with atherosclerotic renal artery stenosis undergoing renal artery intervention?

Peng M, Jiang XJ, Dong H, Zou YB, Zhang HM, Wu HY, Yang Y.

Curr Med Res Opin. 2015 Jan;31(1):177-82. doi: 10.1185/03007995.2014.960071. Epub 2014 Nov 26.

PMID:
25424908
17.

Ischemic nephropathy/azotemic renovascular disease.

Textor SC, Wilcox CS.

Semin Nephrol. 2000 Sep;20(5):489-502. Review.

PMID:
11022902
18.

[A 93-year-old patient with hypertensive crises and renal failure due to bilateral renal artery stenosis].

Mircheva M, Rathmann N, Diehl S, Krämer BK, Benck U.

MMW Fortschr Med. 2015 Nov 5;157(19):45-6. German. No abstract available.

PMID:
26953408
19.

Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.

Corriere MA, Pearce JD, Edwards MS, Stafford JM, Hansen KJ.

J Vasc Surg. 2008 Sep;48(3):580-7; discussion 587-8. doi: 10.1016/j.jvs.2008.04.050.

Supplemental Content

Support Center